Eliminate
Cancer
from the world

We are developing drugs for pancreatic cancer and small cell lung cancer.

News

2026.04.16

Our CSO, Keiichi Nakayama, spoke at Investor Day Japan 2026. Please take a look here to see highlights from the day.

2026.02.24

Our CSO, Keiichi Nakayama, will be presenting at Investor Day Japan 2026. Please see here for more details.

2026.01.27

We have compiled a list of our R&D project selection results. You can view the full list of selected projects here.

See More

Research Content

We are working on developing innovative treatments for highly malignant cancers (pancreatic cancer, small cell lung cancer, etc.)

Small Cell Lung Cancer Icon

Small Cell Lung Cancer

Developing small molecule compounds that inhibit metabolic enzymes highly expressed in small cell lung cancer, promoting new treatment realization.

Learn More
Pancreatic Cancer Icon

Pancreatic Cancer

Developing antibody therapy targeting signal paths specific to pancreatic cancer stem cells, aiming for clinical application.

Learn More
All Cancers Icon

All Cancers

Developing therapeutic agents targeting all solid tumors by inhibiting cancer stem cell-specific ubiquitin ligase E3.

Learn More